- IBDEI2RH ; ; 04-FEB-2020
- ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
- Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
- Q Q
- ;;^UTILITY(U,$J,358.3,44043,1,4,0)
- ;;=4^G25.79
- ;;^UTILITY(U,$J,358.3,44043,2)
- ;;=^5003800
- ;;^UTILITY(U,$J,358.3,44044,0)
- ;;=T43.205A^^164^2176^4
- ;;^UTILITY(U,$J,358.3,44044,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,44044,1,3,0)
- ;;=3^Antidepressant Discontinuation Syndrome,Init Encntr
- ;;^UTILITY(U,$J,358.3,44044,1,4,0)
- ;;=4^T43.205A
- ;;^UTILITY(U,$J,358.3,44044,2)
- ;;=^5050540
- ;;^UTILITY(U,$J,358.3,44045,0)
- ;;=T43.205D^^164^2176^5
- ;;^UTILITY(U,$J,358.3,44045,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,44045,1,3,0)
- ;;=3^Antidepressant Discontinuation Syndrome,Subseq Encntr
- ;;^UTILITY(U,$J,358.3,44045,1,4,0)
- ;;=4^T43.205D
- ;;^UTILITY(U,$J,358.3,44045,2)
- ;;=^5050541
- ;;^UTILITY(U,$J,358.3,44046,0)
- ;;=T43.205S^^164^2176^6
- ;;^UTILITY(U,$J,358.3,44046,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,44046,1,3,0)
- ;;=3^Antidepressant Discontinuation Syndrome,Sequela
- ;;^UTILITY(U,$J,358.3,44046,1,4,0)
- ;;=4^T43.205S
- ;;^UTILITY(U,$J,358.3,44046,2)
- ;;=^5050542
- ;;^UTILITY(U,$J,358.3,44047,0)
- ;;=G25.71^^164^2176^7
- ;;^UTILITY(U,$J,358.3,44047,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,44047,1,3,0)
- ;;=3^Medication-Induced Acute Akathisia
- ;;^UTILITY(U,$J,358.3,44047,1,4,0)
- ;;=4^G25.71
- ;;^UTILITY(U,$J,358.3,44047,2)
- ;;=^5003799
- ;;^UTILITY(U,$J,358.3,44048,0)
- ;;=G24.02^^164^2176^8
- ;;^UTILITY(U,$J,358.3,44048,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,44048,1,3,0)
- ;;=3^Medication-Induced Acute Dystonia
- ;;^UTILITY(U,$J,358.3,44048,1,4,0)
- ;;=4^G24.02
- ;;^UTILITY(U,$J,358.3,44048,2)
- ;;=^5003785
- ;;^UTILITY(U,$J,358.3,44049,0)
- ;;=G21.0^^164^2176^12
- ;;^UTILITY(U,$J,358.3,44049,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,44049,1,3,0)
- ;;=3^Neuroleptic Malignant Syndrome
- ;;^UTILITY(U,$J,358.3,44049,1,4,0)
- ;;=4^G21.0
- ;;^UTILITY(U,$J,358.3,44049,2)
- ;;=^5003771
- ;;^UTILITY(U,$J,358.3,44050,0)
- ;;=T50.905A^^164^2176^1
- ;;^UTILITY(U,$J,358.3,44050,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,44050,1,3,0)
- ;;=3^Adverse Effect of Medication,Other,Init Encntr
- ;;^UTILITY(U,$J,358.3,44050,1,4,0)
- ;;=4^T50.905A
- ;;^UTILITY(U,$J,358.3,44050,2)
- ;;=^5052160
- ;;^UTILITY(U,$J,358.3,44051,0)
- ;;=T50.905S^^164^2176^2
- ;;^UTILITY(U,$J,358.3,44051,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,44051,1,3,0)
- ;;=3^Adverse Effect of Medication,Other,Sequela
- ;;^UTILITY(U,$J,358.3,44051,1,4,0)
- ;;=4^T50.905S
- ;;^UTILITY(U,$J,358.3,44051,2)
- ;;=^5052162
- ;;^UTILITY(U,$J,358.3,44052,0)
- ;;=T50.905D^^164^2176^3
- ;;^UTILITY(U,$J,358.3,44052,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,44052,1,3,0)
- ;;=3^Adverse Effect of Medication,Other,Subseq Encntr
- ;;^UTILITY(U,$J,358.3,44052,1,4,0)
- ;;=4^T50.905D
- ;;^UTILITY(U,$J,358.3,44052,2)
- ;;=^5052161
- ;;^UTILITY(U,$J,358.3,44053,0)
- ;;=F45.22^^164^2177^1
- ;;^UTILITY(U,$J,358.3,44053,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,44053,1,3,0)
- ;;=3^Body Dysmorphic D/O
- ;;^UTILITY(U,$J,358.3,44053,1,4,0)
- ;;=4^F45.22
- ;;^UTILITY(U,$J,358.3,44053,2)
- ;;=^5003588
- ;;^UTILITY(U,$J,358.3,44054,0)
- ;;=F63.3^^164^2177^8
- ;;^UTILITY(U,$J,358.3,44054,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,44054,1,3,0)
- ;;=3^Trichotillomania (Hair-Pulling D/O)
- ;;^UTILITY(U,$J,358.3,44054,1,4,0)
- ;;=4^F63.3
- ;;^UTILITY(U,$J,358.3,44054,2)
- ;;=^5003643
- ;;^UTILITY(U,$J,358.3,44055,0)
- ;;=F06.8^^164^2177^4
- ;;^UTILITY(U,$J,358.3,44055,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,44055,1,3,0)
- ;;=3^OCD & Rel D/O d/t Phys Cond
- --- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI2RH 3789 printed Feb 19, 2025@00:00:50 Page 2
- IBDEI2RH ; ; 04-FEB-2020
- +1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
- +2 if 'DIFQR(358.3)
- QUIT
- FOR I=1:2
- SET X=$TEXT(Q+I)
- if X=""
- QUIT
- SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
- SET X=$EXTRACT(X,4,999)
- if $ASCII(Y)=126
- SET I=I+1
- SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
- if $ASCII(Y)=61
- SET Y=$EXTRACT(Y,2,999)
- XECUTE NO
- IF '$TEST
- SET @X=Y
- Q QUIT
- +1 ;;^UTILITY(U,$J,358.3,44043,1,4,0)
- +2 ;;=4^G25.79
- +3 ;;^UTILITY(U,$J,358.3,44043,2)
- +4 ;;=^5003800
- +5 ;;^UTILITY(U,$J,358.3,44044,0)
- +6 ;;=T43.205A^^164^2176^4
- +7 ;;^UTILITY(U,$J,358.3,44044,1,0)
- +8 ;;=^358.31IA^4^2
- +9 ;;^UTILITY(U,$J,358.3,44044,1,3,0)
- +10 ;;=3^Antidepressant Discontinuation Syndrome,Init Encntr
- +11 ;;^UTILITY(U,$J,358.3,44044,1,4,0)
- +12 ;;=4^T43.205A
- +13 ;;^UTILITY(U,$J,358.3,44044,2)
- +14 ;;=^5050540
- +15 ;;^UTILITY(U,$J,358.3,44045,0)
- +16 ;;=T43.205D^^164^2176^5
- +17 ;;^UTILITY(U,$J,358.3,44045,1,0)
- +18 ;;=^358.31IA^4^2
- +19 ;;^UTILITY(U,$J,358.3,44045,1,3,0)
- +20 ;;=3^Antidepressant Discontinuation Syndrome,Subseq Encntr
- +21 ;;^UTILITY(U,$J,358.3,44045,1,4,0)
- +22 ;;=4^T43.205D
- +23 ;;^UTILITY(U,$J,358.3,44045,2)
- +24 ;;=^5050541
- +25 ;;^UTILITY(U,$J,358.3,44046,0)
- +26 ;;=T43.205S^^164^2176^6
- +27 ;;^UTILITY(U,$J,358.3,44046,1,0)
- +28 ;;=^358.31IA^4^2
- +29 ;;^UTILITY(U,$J,358.3,44046,1,3,0)
- +30 ;;=3^Antidepressant Discontinuation Syndrome,Sequela
- +31 ;;^UTILITY(U,$J,358.3,44046,1,4,0)
- +32 ;;=4^T43.205S
- +33 ;;^UTILITY(U,$J,358.3,44046,2)
- +34 ;;=^5050542
- +35 ;;^UTILITY(U,$J,358.3,44047,0)
- +36 ;;=G25.71^^164^2176^7
- +37 ;;^UTILITY(U,$J,358.3,44047,1,0)
- +38 ;;=^358.31IA^4^2
- +39 ;;^UTILITY(U,$J,358.3,44047,1,3,0)
- +40 ;;=3^Medication-Induced Acute Akathisia
- +41 ;;^UTILITY(U,$J,358.3,44047,1,4,0)
- +42 ;;=4^G25.71
- +43 ;;^UTILITY(U,$J,358.3,44047,2)
- +44 ;;=^5003799
- +45 ;;^UTILITY(U,$J,358.3,44048,0)
- +46 ;;=G24.02^^164^2176^8
- +47 ;;^UTILITY(U,$J,358.3,44048,1,0)
- +48 ;;=^358.31IA^4^2
- +49 ;;^UTILITY(U,$J,358.3,44048,1,3,0)
- +50 ;;=3^Medication-Induced Acute Dystonia
- +51 ;;^UTILITY(U,$J,358.3,44048,1,4,0)
- +52 ;;=4^G24.02
- +53 ;;^UTILITY(U,$J,358.3,44048,2)
- +54 ;;=^5003785
- +55 ;;^UTILITY(U,$J,358.3,44049,0)
- +56 ;;=G21.0^^164^2176^12
- +57 ;;^UTILITY(U,$J,358.3,44049,1,0)
- +58 ;;=^358.31IA^4^2
- +59 ;;^UTILITY(U,$J,358.3,44049,1,3,0)
- +60 ;;=3^Neuroleptic Malignant Syndrome
- +61 ;;^UTILITY(U,$J,358.3,44049,1,4,0)
- +62 ;;=4^G21.0
- +63 ;;^UTILITY(U,$J,358.3,44049,2)
- +64 ;;=^5003771
- +65 ;;^UTILITY(U,$J,358.3,44050,0)
- +66 ;;=T50.905A^^164^2176^1
- +67 ;;^UTILITY(U,$J,358.3,44050,1,0)
- +68 ;;=^358.31IA^4^2
- +69 ;;^UTILITY(U,$J,358.3,44050,1,3,0)
- +70 ;;=3^Adverse Effect of Medication,Other,Init Encntr
- +71 ;;^UTILITY(U,$J,358.3,44050,1,4,0)
- +72 ;;=4^T50.905A
- +73 ;;^UTILITY(U,$J,358.3,44050,2)
- +74 ;;=^5052160
- +75 ;;^UTILITY(U,$J,358.3,44051,0)
- +76 ;;=T50.905S^^164^2176^2
- +77 ;;^UTILITY(U,$J,358.3,44051,1,0)
- +78 ;;=^358.31IA^4^2
- +79 ;;^UTILITY(U,$J,358.3,44051,1,3,0)
- +80 ;;=3^Adverse Effect of Medication,Other,Sequela
- +81 ;;^UTILITY(U,$J,358.3,44051,1,4,0)
- +82 ;;=4^T50.905S
- +83 ;;^UTILITY(U,$J,358.3,44051,2)
- +84 ;;=^5052162
- +85 ;;^UTILITY(U,$J,358.3,44052,0)
- +86 ;;=T50.905D^^164^2176^3
- +87 ;;^UTILITY(U,$J,358.3,44052,1,0)
- +88 ;;=^358.31IA^4^2
- +89 ;;^UTILITY(U,$J,358.3,44052,1,3,0)
- +90 ;;=3^Adverse Effect of Medication,Other,Subseq Encntr
- +91 ;;^UTILITY(U,$J,358.3,44052,1,4,0)
- +92 ;;=4^T50.905D
- +93 ;;^UTILITY(U,$J,358.3,44052,2)
- +94 ;;=^5052161
- +95 ;;^UTILITY(U,$J,358.3,44053,0)
- +96 ;;=F45.22^^164^2177^1
- +97 ;;^UTILITY(U,$J,358.3,44053,1,0)
- +98 ;;=^358.31IA^4^2
- +99 ;;^UTILITY(U,$J,358.3,44053,1,3,0)
- +100 ;;=3^Body Dysmorphic D/O
- +101 ;;^UTILITY(U,$J,358.3,44053,1,4,0)
- +102 ;;=4^F45.22
- +103 ;;^UTILITY(U,$J,358.3,44053,2)
- +104 ;;=^5003588
- +105 ;;^UTILITY(U,$J,358.3,44054,0)
- +106 ;;=F63.3^^164^2177^8
- +107 ;;^UTILITY(U,$J,358.3,44054,1,0)
- +108 ;;=^358.31IA^4^2
- +109 ;;^UTILITY(U,$J,358.3,44054,1,3,0)
- +110 ;;=3^Trichotillomania (Hair-Pulling D/O)
- +111 ;;^UTILITY(U,$J,358.3,44054,1,4,0)
- +112 ;;=4^F63.3
- +113 ;;^UTILITY(U,$J,358.3,44054,2)
- +114 ;;=^5003643
- +115 ;;^UTILITY(U,$J,358.3,44055,0)
- +116 ;;=F06.8^^164^2177^4
- +117 ;;^UTILITY(U,$J,358.3,44055,1,0)
- +118 ;;=^358.31IA^4^2
- +119 ;;^UTILITY(U,$J,358.3,44055,1,3,0)
- +120 ;;=3^OCD & Rel D/O d/t Phys Cond